Comparing cardiovascular adverse events in cancer patients: A meta-analysis of combination therapy with angiogenesis inhibitors and immune checkpoint inhibitors versus angiogenesis inhibitors alone

Overview

cited authors

Crocetto, Felice; Ferro, Matteo; Buonerba, Carlo; Bardi, Luca; Dolce, Pasquale; Scafuri, Luca; Mirto, Benito Fabio; Verde, Antonio; Sciarra, Antonella; Barone, Biagio; Calogero, Armando; Sagnelli, Caterina; Busetto, Gian Maria; Del Giudice, Francesco; Cilio, Simone; Sonpavde, Guru; Di Trolio, Rossella; Della Ratta, Giuseppe Luca; Barbato, Gabriele; Di Lorenzo, Giuseppe

authors

Sonpavde, Guru, MD

Publication Date

August 1, 2023

webpage

Web of Science

published in

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY Journal

Research

keywords

Angiogenesis inhibitors
Cardiovascular toxicity
Immune checkpoint inhibitors

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.